Author Biographies

N/A
N/A
N/A
N/A
N/A
Min Luo has a position as an assistant professor and currently works at the Department of Biological Sciences, National University of Singapore, Singapore. He received his B.Sc. from Shandong University, Jinan, China, and his Ph.D. from the University of Missouri-Columbia, Columbia, MO, USA. He was a postdoctoral researcher at the Harvard Medical School, Boston, MA, USA. He focuses on the study of challenging transmembrane proteins. Currently, his primary interest is to combine biochemical and biophysical techniques to address fundamental questions in important drug targets of membrane proteins in mitochondria, specifically on their regulation in iron/ROS homeostasis and mitochondrial morphology.
Prof. Dr. Paul Anantharajah Tambyah is currently a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, a Professor of Medicine at the Infectious Diseases Translational Research ProgramYong Loo Lin School of Medicine & Honorary Joint Professor at NUS CBmE and visiting Consultant at the National Center for Infectious Diseases. He is currently the President of the International Society for Infectious Diseases and immediate Past President of the Asia Pacific Society of Clinical Microbiology and Infection. His past appointments include the founding head of the Division of Infectious Diseases in NUS, the Assistant Dean at Yong Loo Lin School of Medicine (YLLSOM), and a board member of the Society of Healthcare Epidemiology in America. His main research interests are in emerging infectious diseases and hospital-acquired infections.
Dr. Yee-Joo Tan obtained a Ph.D. degree from the University of Cambridge in 1997.  She is currently an associate professor at the Infectious Diseases Translational Research Program and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore.  Her research interests mainly include the characterization of newly emerged viruses and hepatitis viruses, the development of antibodies for diagnostic and therapeutic applications, and protein engineering.
clear